Cédric Leprince Email & Phone Number

Greater Paris Metropolitan Region

Worldwide management of a portfolio of injectable biologic drugs worthing 500 M€+ spread across North America, Europe, Asia and key emerging markets. As a genuine champion for the rapid acting insulins portfolio, lead a multidisciplinary and transversal experts core team to timely and successfully address key business’ makers and mitigate breakers. Steer and deliver portfolio strategy, mid and long-term business planning exercises and investors call preparation jointly with Finance. Drive insights based decision making and endorse all pivotal decisions to maximize portfolio’s growth and profitability in close collaboration with Global Executive LT and Regional/Local key stakeholders. Shape individualized Go to Market models and market access / pricing strategies to maximize each market archetype potential. Assess and ignite business development opportunities, life cycle management (LCM) and portfolio optimization strategic projects, from business case building, investment committee preparation, towards final execution in full alignment with Global BU strategic roadmap. Ensure continuous competitive intelligence and regulatory trends monitoring to timely adapt strategy to achieve profitable growth. Selected Contributions: Redefined portfolio strategy and transformed Go to Market to lift-up BOI by +15% in 4 years Achieved continuous sales acceleration overperforming market growth on the last 3 years Signed and executed strategic deals with three worldwide insulin pumps manufacturers leaders Led long range forecasting exercise to support major CAPEX decision making from the ExCom